IOBT
IO Biotech Inc
NASDAQ: IOBT · HEALTHCARE · BIOTECHNOLOGY
$0.05
+0.00% today
Updated 2026-04-07
Market cap
$2.32M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-1.34
Dividend yield
—
52W range
$0 – $3
Volume
14.5M
IO Biotech Inc (IOBT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Operating cash flow | $-8.89M | $-9.96M | $-40.65M | $-59.73M | $-71.74M | $-82.35M |
| Capital expenditures | $153000.00 | $153000.00 | $153000.00 | $690000.00 | $323000.00 | $44000.00 |
| Depreciation | — | — | — | — | — | — |
| Stock-based comp | $131000.00 | $64000.00 | $1.79M | $7.04M | $8.06M | $6.53M |
| Free cash flow | $-9.04M | $-10.11M | $-40.80M | $-60.42M | $-72.06M | $-82.39M |
| Investing cash flow | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — |
| Net change in cash | — | — | — | $-60.42M | — | — |